ROS inhibitors: Apocynin 100uM (Millipore 498-02-2), gp91 ds-tat 10uM (Anaspec AS-63818), sgp91 10uM (Anaspec 63821), phorbol 12-myristate 13-acetate (PMA) 100 nM (Caymen 10008014), Rotenone 5uM (Sigma 13995), N-acetyl-l-cysteine (NAC) 5 mM (Sigma 1009005) and Diphenyleneiodonium chloride (DPI) (Selleckchem S8639) and 100 M Butathione Sulfoximine (BSO) (Caymen 14484)
265,266 TBI is increasingly recognized as a metabolic disorder, with lactate accumulation linked to poor prognosis
The IV Therapy Advantage Administering through intravenous (IV) therapy offers several benefits over traditional oral supplementation, optimizing its effectiveness in the body: Enhanced Bioavailability Unlike oral supplements, which can be degraded by digestive enzymes, IV glutathione is delivered directly into the bloodstream, bypassing the digestive tract
10.5897/jmpr11.1258 7 Al-MalkiA
"Global reconstruction of the human metabolic network based on genomic and bibliomic data"
